Abstract
Cardiovascular diseases have a high mortality due to a very limited regenerative potential of lost cardiomyocytes and therefore are one of the leading causes of death in developed countries [...].
MeSH terms
-
Cardiovascular Diseases* / therapy
-
Global Health
-
Humans
-
Myocytes, Cardiac
Grants and funding
R.D. is supported by the EU Structural Fund (ESF/14-BMA55-0024/18) and the FORUN Program of Rostock University Medical Centre. R.D. is further supported by the DFG (DA1296/6-1), the DAMP foundation, the German Heart Foundation (F/01/12), the BMBF (VIP + 00240) and the Josef and Käthe Klinz Foundation (T319/29737/2017).